EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Trh and gonadotropin releasing hormone test to predict effectiveness of bromocriptine therapy in infertile women


Fertility and Sterility 46(5): 846-851
Trh and gonadotropin releasing hormone test to predict effectiveness of bromocriptine therapy in infertile women
Sixty-four infertile women presenting with luteal phase defect, anovulatory cycle, and secondary amenorrhea were compared with 15 normal cycling women with bolus injections of thyrotropin-releasing hormone (TRH) and gonadotropin-releasing hormone (GnRH) before bromocriptine (BCPT) therapy. All of the women had normal baseline prolactin (PRL), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) concentrations. Responses of PRL, LH, and FSH levels were measured.


Accession: 006839674



Related references

Thyrotropin-releasing hormone and gonadotropin-releasing hormone test to predict effectiveness of bromocriptine therapy in infertile women. Fertility and Sterility 46(5): 846-851, 1986

Comparative cost and clinical effectiveness of pulsatile gonadotropin releasing hormone and human menopausal gonadotropin therapy for infertile women with hypogonadotropic hypogonadism. Journal of Endocrinology 111(SUPPL), 1986

Pulsatile intravenous gonadotropin-releasing hormone for ovulation-induction in infertile women. I. Safety and effectiveness with outpatient therapy. Fertility and Sterility 48(1): 33-38, 1987

Alternative indications for pulsatile gonadotropin-releasing hormone therapy in infertile women. Fertility and Sterility 44(5): 589-594, 1985

Pulsatile gonadotropin releasing hormone therapy an alternative successful therapy for induction of ovulation in infertile normoprolactinemic and hyperprolactinemic amenorrheic women with pituitary tumors. Acta Endocrinologica 110(4): 440-444, 1985

Comparison of gonadotropin releasing hormone agonist long protocol and gonadotropin releasing hormone antagonist protocol in infertile women. Beijing Da Xue Xue Bao. Yi Xue Ban 45(6): 877-881, 2014

The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro. Journal of Clinical Endocrinology and Metabolism 64(3): 524-530, 1987

Pituitary testicular function in immature rats after treatment with gonadotropin releasing hormone antagonist gonadotropin releasing hormone anti serum and bromocriptine. Molecular & Cellular Endocrinology 34(2): 137-144, 1984

Effect of treatment with gonadotropin releasing hormone antagonist gonadotropin releasing hormone anti serum and bromocriptine on pituitary testicular function of adult rats. Molecular & Cellular Endocrinology 34(2): 127-136, 1984

Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. Journal of Clinical Endocrinology and Metabolism 68(6): 1128-1135, 1989